References
- Marrouche NF, Dresing T, Bash D, Saad E, Balaban K, Pavia SV, et al.
Circular mapping and ablation of the pulmonary veins for treatment of
atrial fibrillation: Impact of different catheter technologies. J Am
Coll Cardiol 2002; 40: 464– 474.
- Hachiya H, Hirao K, Takahashi A, Nagata Y, Suzuki K, Maeda S, et al.
Clinical implications of reconnection between the left atrium and
isolated pulmonary veins provoked by adenosine triphosphate after
extensive pulmonary vein isolation. J Cardiovasc Electrophysiol 2007;
18: 392–398.
- Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, et al.
Complete isolation of left atrium surrounding the pulmonary veins: New
insights from the double-Lasso technique in paroxysmal atrial
fibrillation. Circulation 2004; 110: 2090– 2096
- Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy
D, et al. Ablation versus amiodarone for treatment of persistent
atrial fibrillation in patients with congestive heart failure and an
implanted device: Results from the AATAC multicenter randomized trial.
Circulation 2016; 133: 1637–1644
- Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens
L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H,
Vogt J, Bansch D. Catheter ablation for atrial fibrillation with heart
failure. N Engl J Med 2018;378:417–427.
- Asad ZUA, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter
ablation versus medical therapy for atrial fibrillation. Circulation:
Arrhythmia and Electrophysiology. 2019;12:e007414
- Sessions AJ, May HT, Crandall BG, Day JD, Cutler DO MJ, Groh CA, et
al. Increasing time between first diagnosis of atrial fibrillation and
catheter ablation adversely affects long-term outcomes in patients
with and without structural heart disease. J Cardiovasc Electrophysiol
2023; 34
- Akihiko Nogami*; Takashi Kurita*; Haruhiko Abe; Kenji Ando; Toshiyuki
Ishikawa; Katsuhiko Imai; Akihiko Usui; Kaoru Okishige; Kengo Kusano;
Koichiro Kumagai; Masahiko Goya; Yoshinori Kobayashi; Akihiko Shimizu;
Wataru Shimizu; Morio Shoda; Naokata Sumitomo; Yoshihiro Seo; Atsushi
Takahashi; Hiroshi Tada; Shigeto Naito; Yuji Nakazato; Takashi
Nishimura; Takashi Nitta; Shinichi Niwano; Nobuhisa Hagiwara; Yuji
Murakawa; Teiichi Yamane; Takeshi Aiba; Koichi Inoue; Yuki Iwasaki;
Yasuya Inden; Kikuya Uno; Michio Ogano; Masaomi Kimura; Shun-ichiro
Sakamoto; Shingo Sasaki; Kazuhiro Satomi; Tsuyoshi Shiga; Tsugutoshi
Suzuki; Yukio Sekiguchi; Kyoko Soejima; Masahiko Takagi; Masaomi
Chinushi; Nobuhiro Nishi; Takashi Noda; Hitoshi Hachiya; Masataka
Mitsuno; Takeshi Mitsuhashi; Yasushi Miyauchi; Aya Miyazaki; Tomoshige
Morimoto; Hiro Yamasaki; Yoshifusa Aizawa; Tohru Ohe; Takeshi Kimura;
Kazuo Tanemoto; Hiroyuki Tsutsui; Hideo Mitamura on behalf of the
JCS/JHRS Joint Working Group. JCS/JHRS 2019 Guideline on
Non-Pharmacotherapy of Cardiac Arrhythmias. Circ J 2021; 85:
1692–1700
- Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, et al.
How to diagnose heart failure with preserved ejection fraction: The
hfa-peff diagnostic algorithm: A consensus recommendation from the
heart failure association (hfa) of the european society of cardiology
(esc). Eur J Heart Fail. 2020;22:391-412
- Ichijo S, Miyazaki S, Kusa S, Nakamura H, Hachiya H, Kajiyama T, et
al. Impact of catheter ablation of atrial fibrillation on long-term
clinical outcomes in patients with heart failure. Journal of
Cardiology 2018; 72: 240–246
- Rolf S, Kircher S, Arya A et al. Tailored atrial substrate
modification based on low-voltage areas in catheter ablation of atrial
fibrillation. Circ Arrhythm Electrophysiol.2014;7:825-33.
- Prabhu S, Taylor AJ, Costello BT, et al. Catheter Ablation Versus
Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction:
The CAMERA-MRI Study. J Am Coll Cardiol 2017;70: 1949–61.